Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -327,370 | -411,472 | -346,028 | -314,670 | -198,471 |
| Depreciation Amortization | 12,812 | 4,893 | 3,335 | 6,421 | 6,481 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 1,346 |
| Accounts receivable | N/A | N/A | -5,090 | 2,438 | 3,339 |
| Accounts payable and accrued liabilities | 3,330 | 4,162 | -5,488 | 5,329 | 3,501 |
| Other Working Capital | 1,965 | -7,275 | -35,105 | -24,832 | 187,120 |
| Other Operating Activity | 18,504 | 39,070 | 83,955 | 40,082 | 35,246 |
| Operating Cash Flow | $-290,759 | $-370,622 | $-304,421 | $-285,232 | $38,562 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14,106 | -12,028 | -6,986 | -4,627 | -9,915 |
| Purchase Of Investment | -557,030 | -488,566 | -933,320 | -688,702 | -506,067 |
| Sale Of Investment | 647,685 | 592,177 | 666,481 | 635,421 | 396,632 |
| Other Investing Activity | -803 | -143 | 0 | 0 | 0 |
| Investing Cash Flow | $75,746 | $91,440 | $-273,825 | $-57,908 | $-119,350 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -336 | -113 | 0 | N/A | N/A |
| Common Stock Issued | 11,317 | 289,724 | 546,415 | 284,472 | 170,008 |
| Other Financing Activity | 250,537 | 0 | -391 | 638 | -230 |
| Financing Cash Flow | $261,518 | $289,611 | $546,024 | $285,110 | $169,778 |
| Beginning Cash Position | 80,931 | 70,502 | 102,724 | 160,754 | 71,764 |
| End Cash Position | 127,436 | 80,931 | 70,502 | 102,724 | 160,754 |
| Net Cash Flow | $46,505 | $10,429 | $-32,222 | $-58,030 | $88,990 |
| Free Cash Flow | |||||
| Operating Cash Flow | -290,759 | -370,622 | -304,421 | -285,232 | 38,562 |
| Capital Expenditure | -14,106 | -12,028 | -6,986 | -4,627 | -9,915 |
| Free Cash Flow | -304,865 | -382,650 | -311,407 | -289,859 | 28,647 |